Gastric cancer staging

Matthew Dixon, Abraham El-Sedfy, Natalie Coburn

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Worldwide, gastric adenocarcinoma is one of the most commonly found malignancies, and one of the most common causes of cancer-related death. Although adjuvant therapies have improved survival, resection remains the fundamental curative option for gastric cancer patients. Accurate staging forms the basis for which treatments are selected. An understanding of the staging systems commonly used is important for physicians involved in the treatment of gastric cancer. In addition, several staging modalities are routinely prescribed in an attempt to accurately stage the patient with gastric cancer. Each of these staging modalities has their own benefits and drawbacks with varying degrees of accuracy, sensitivity and specificity. The following staging modalities will be reviewed in detail: computed tomography, magnetic resonance imaging, abdominal ultrasound, 18Fluorodeoxyglucose-positron emission tomography, esophagogastroduodenoscopy, endoscopic ultrasound, staging laparoscopy, peritoneal cytology and sentinel lymph node biopsy. The ultimate goal is correlation between staging modalities and pathology findings such that accurate staging is performed with delivery of the most appropriate stage-specific treatment.

Original languageEnglish (US)
Title of host publicationGastric Cancer
Subtitle of host publicationRisk Factors, Treatment and Clinical Outcomes
PublisherNova Science Publishers, Inc.
Pages57-87
Number of pages31
ISBN (Electronic)9781631179907
ISBN (Print)9781631179839
StatePublished - Jul 1 2014

Fingerprint

Neoplasm Staging
Stomach Neoplasms
Digestive System Endoscopy
Sentinel Lymph Node Biopsy
Therapeutics
Positron-Emission Tomography
Laparoscopy
Cell Biology
Neoplasms
Stomach
Adenocarcinoma
Tomography
Magnetic Resonance Imaging
Pathology
Physicians
Sensitivity and Specificity
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Dixon, M., El-Sedfy, A., & Coburn, N. (2014). Gastric cancer staging. In Gastric Cancer: Risk Factors, Treatment and Clinical Outcomes (pp. 57-87). Nova Science Publishers, Inc..
Dixon, Matthew ; El-Sedfy, Abraham ; Coburn, Natalie. / Gastric cancer staging. Gastric Cancer: Risk Factors, Treatment and Clinical Outcomes. Nova Science Publishers, Inc., 2014. pp. 57-87
@inbook{6b1d16ffcf73482491e09c40390eed37,
title = "Gastric cancer staging",
abstract = "Worldwide, gastric adenocarcinoma is one of the most commonly found malignancies, and one of the most common causes of cancer-related death. Although adjuvant therapies have improved survival, resection remains the fundamental curative option for gastric cancer patients. Accurate staging forms the basis for which treatments are selected. An understanding of the staging systems commonly used is important for physicians involved in the treatment of gastric cancer. In addition, several staging modalities are routinely prescribed in an attempt to accurately stage the patient with gastric cancer. Each of these staging modalities has their own benefits and drawbacks with varying degrees of accuracy, sensitivity and specificity. The following staging modalities will be reviewed in detail: computed tomography, magnetic resonance imaging, abdominal ultrasound, 18Fluorodeoxyglucose-positron emission tomography, esophagogastroduodenoscopy, endoscopic ultrasound, staging laparoscopy, peritoneal cytology and sentinel lymph node biopsy. The ultimate goal is correlation between staging modalities and pathology findings such that accurate staging is performed with delivery of the most appropriate stage-specific treatment.",
author = "Matthew Dixon and Abraham El-Sedfy and Natalie Coburn",
year = "2014",
month = "7",
day = "1",
language = "English (US)",
isbn = "9781631179839",
pages = "57--87",
booktitle = "Gastric Cancer",
publisher = "Nova Science Publishers, Inc.",

}

Dixon, M, El-Sedfy, A & Coburn, N 2014, Gastric cancer staging. in Gastric Cancer: Risk Factors, Treatment and Clinical Outcomes. Nova Science Publishers, Inc., pp. 57-87.

Gastric cancer staging. / Dixon, Matthew; El-Sedfy, Abraham; Coburn, Natalie.

Gastric Cancer: Risk Factors, Treatment and Clinical Outcomes. Nova Science Publishers, Inc., 2014. p. 57-87.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Gastric cancer staging

AU - Dixon, Matthew

AU - El-Sedfy, Abraham

AU - Coburn, Natalie

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Worldwide, gastric adenocarcinoma is one of the most commonly found malignancies, and one of the most common causes of cancer-related death. Although adjuvant therapies have improved survival, resection remains the fundamental curative option for gastric cancer patients. Accurate staging forms the basis for which treatments are selected. An understanding of the staging systems commonly used is important for physicians involved in the treatment of gastric cancer. In addition, several staging modalities are routinely prescribed in an attempt to accurately stage the patient with gastric cancer. Each of these staging modalities has their own benefits and drawbacks with varying degrees of accuracy, sensitivity and specificity. The following staging modalities will be reviewed in detail: computed tomography, magnetic resonance imaging, abdominal ultrasound, 18Fluorodeoxyglucose-positron emission tomography, esophagogastroduodenoscopy, endoscopic ultrasound, staging laparoscopy, peritoneal cytology and sentinel lymph node biopsy. The ultimate goal is correlation between staging modalities and pathology findings such that accurate staging is performed with delivery of the most appropriate stage-specific treatment.

AB - Worldwide, gastric adenocarcinoma is one of the most commonly found malignancies, and one of the most common causes of cancer-related death. Although adjuvant therapies have improved survival, resection remains the fundamental curative option for gastric cancer patients. Accurate staging forms the basis for which treatments are selected. An understanding of the staging systems commonly used is important for physicians involved in the treatment of gastric cancer. In addition, several staging modalities are routinely prescribed in an attempt to accurately stage the patient with gastric cancer. Each of these staging modalities has their own benefits and drawbacks with varying degrees of accuracy, sensitivity and specificity. The following staging modalities will be reviewed in detail: computed tomography, magnetic resonance imaging, abdominal ultrasound, 18Fluorodeoxyglucose-positron emission tomography, esophagogastroduodenoscopy, endoscopic ultrasound, staging laparoscopy, peritoneal cytology and sentinel lymph node biopsy. The ultimate goal is correlation between staging modalities and pathology findings such that accurate staging is performed with delivery of the most appropriate stage-specific treatment.

UR - http://www.scopus.com/inward/record.url?scp=84956801452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956801452&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84956801452

SN - 9781631179839

SP - 57

EP - 87

BT - Gastric Cancer

PB - Nova Science Publishers, Inc.

ER -

Dixon M, El-Sedfy A, Coburn N. Gastric cancer staging. In Gastric Cancer: Risk Factors, Treatment and Clinical Outcomes. Nova Science Publishers, Inc. 2014. p. 57-87